Conservative management of endometrial hyperplasia or carcinoma with the levonorgestrel intrauterine system may be less effective in morbidly obese patients

Ashley Graul; Elise Wilson; Emily Ko; Ashley F. Haggerty; Helen Reed; Nathanael Koelper; Sarah H. Kim

首页> 外文期刊>Gynecologic Oncology Reports >Conservative management of endometrial hyperplasia or carcinoma with the levonorgestrel intrauterine system may be less effective in morbidly obese patients

【24h】

Conservative management of endometrial hyperplasia or carcinoma with the levonorgestrel intrauterine system may be less effective in morbidly obese patients

机译：左炔诺孕酮宫内节育器对子宫内膜增生或癌的保守治疗在病态肥胖患者中可能无效

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Highlights

?Endometrial hyperplasia/carcinoma regression rates with LNG-IUS were examined by BMI.

?Morbidly obese patients with EH/EHA/EC are more likely to progress.

?Despite addition of oral progesterone to LNG-IUS, morbid obesity increases the odds of progression.

机译：

突出显示

？通过BMI检查了LNG-IUS对子宫内膜增生/癌的消退率。

？患有EH / EHA的肥胖症患者/ EC更有可能取得进展。

？尽管向LNG-IUS添加口服黄体酮，病态肥胖增加了进展的几率。 < / ce：simple-para>

著录项

来源
《Gynecologic Oncology Reports》 |2018年第2期|共4页
作者
Ashley Graul; Elise Wilson; Emily Ko; Ashley F. Haggerty; Helen Reed; Nathanael Koelper; Sarah H. Kim;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. S9. Conservative management of atypical endometrial hyperplasia and early invasive carcinoma with intrauterine levonorgestrel: a progesterone receptor study'' [J] . European Journal of Cancer Supplements . 2004,第9期

机译：S9。非典型子宫内膜增生和宫腔内左炔诺孕酮的早期浸润癌的保守治疗：孕激素受体研究''
2. S9. Conservative management of atypical endometrial hyperplasia and early invasive carcinoma with intrauterine levonorgestrel: a progesterone receptor study'' [J] . European Journal of Cancer Supplements . 2004,第9期

机译：S9。非典型子宫内膜增生和宫腔内左炔诺孕酮的早期浸润癌的保守治疗：孕激素受体研究''
3. Efficacy of the levonorgestrel intrauterine system (LNG-IUS) in the prevention of the atypical endometrial hyperplasia and endometrial cancer: Retrospective data from selected obese menopausal symptomatic women [J] . MorelliM., DiCelloA., VenturellaR., Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology . 2013,第2期

机译：左炔诺孕酮子宫内系统（LNG-IUS）在预防非典型子宫内膜增生和子宫内膜癌中的作用：某些肥胖的更年期有症状女性的回顾性数据
4. Laparoscopic Pelvic Lymphadenectomy in Patients with Endometrial Cancer and Morbid Obesity [C] . J. Gilabert, J. Gilabert-Estelles, V. Paya, European Society for Gynecologic Endoscopy . 2006

机译：子宫内膜癌和病态肥胖患者的腹腔镜盆腔切除术
5. Measuring distress in patients with morbid obesity in the United States of America: A replication of the Obesity Adjustment Survey using online patients who are involved with bariatric surgery. [D] . Smith, Susan M. 2006

机译：在美国，测量病态肥胖患者的窘迫：《肥胖调整调查》的一项复制，其中涉及参与减肥手术的在线患者。
6. Conservative management of endometrial hyperplasia or carcinoma with the levonorgestrel intrauterine system may be less effective in morbidly obese patients [O] . Ashley Graul, Elise Wilson, Emily Ko, 2018

机译：左炔诺孕酮宫内节育器对子宫内膜增生或癌的保守治疗在病态肥胖患者中可能无效
7. S9. Conservative management of atypical endometrial hyperplasia and early invasive carcinoma with intrauterine levonorgestrel: a progesterone receptor study” [O] . 2004

机译：S9。子宫内孕烯雌酮对非典型子宫内膜增生和早期浸润癌的保守治疗：孕激素受体研究”

Conservative management of endometrial hyperplasia or carcinoma with the levonorgestrel intrauterine system may be less effective in morbidly obese patients

摘要

著录项

相似文献

相关主题

期刊订阅